Ding, Yangfeng, and Weida Liu. “Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients With Moderate-to-Severe Plaque Psoriasis: A Matching-Adjusted Indirect Comparisons”. Acta Dermato-Venereologica 106 (April 16, 2026): adv–2025. Accessed April 27, 2026. https://medicaljournalssweden.se/actadv/article/view/45950.